FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Weisler

Research Profile

Procedures

Double-Blind Method

Disorders

Concepts & Ideas

Chemicals & Drugs

Devices

Placebos

Co-author Network

Publications

TOP 3
Willem A Nolen; Richard H Weisler
The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Greg W Mattingly; Brian Scheckner; Richard H Weisler; Joel Young; Ben Adeyi; Thomas Babcock; Bryan Dirks; Robert Lasser; David W Goodman
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
Matthew Brams; M Celeste Ferreira-Cornwell; Robert L Findling; Maria Gasior; Mohamed Hamdani; Richard H Weisler; Liza Squires
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Weisler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Willem A Nolen; Richard H Weisler
The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Bipolar disorders 2013;15(1):100-9.
2013: Greg W Mattingly; Brian Scheckner; Richard H Weisler; Joel Young; Ben Adeyi; Thomas Babcock; Bryan Dirks; Robert Lasser; David W Goodman
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
BMC psychiatry 2013;13():39.
2012: Matthew Brams; M Celeste Ferreira-Cornwell; Robert L Findling; Maria Gasior; Mohamed Hamdani; Richard H Weisler; Liza Squires
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
The Journal of clinical psychiatry 2012;73(7):977-83.
2012: Richard H Weisler; Gahan J Pandina; Kimberly Cooper; Ella J Daly; Cristiana Gassmann-Mayer
Randomized clinical study of a histamine h3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
CNS drugs 2012;26(5):421-34.
2012: Richard H Weisler; Kimberly Cooper; Ella J Daly; Cristiana Gassmann-Mayer; Gahan J Pandina
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
CNS drugs 2012;26(5):421-34.
2012: Richard H Weisler; Willie R Earley; Stuart A Montgomery; Johan Szamosi; Arthur Lazarus
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
International clinical psychopharmacology 2012;27(1):27-39.
2011: Leonard J Paulozzi; Richard H Weisler; Ashwin A Patkar
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it.
The Journal of clinical psychiatry 2011;72(5):589-92.
2011: Richard H Weisler; Arif Khan; Madhukar H Trivedi; H Yang; James M Eudicone; A Pikalov; Q V Tran; R M Berman; B X Carlson
Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
The Journal of clinical psychiatry 2011;72(4):548-55.
2011: Richard H Weisler; Ann C Childress
Treating attention-deficit/hyperactivity disorder in adults: focus on once-daily medications.
The primary care companion to CNS disorders 2011;13(6):.
2011: Jennifer J Brown; Richard H Weisler
Posttraumatic stress disorder screening practices: a 2010 internet assessment of customary care.
The primary care companion to CNS disorders 2011;13(5):.
2010: Susan Lenderts; Amir Kalali; Richard H Weisler
Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity.
Psychiatry (Edgmont (Pa. : Township)) 2010;7(2):17-23.
2010: Susan L McElroy; Richard H Weisler; William Chang; Bengt Olausson; Björn Paulsson; Martin Brecher; Vasavan Agambaram; Charles Merideth; Arvid Nordenhem; Allan H Young
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
The Journal of clinical psychiatry 2010;71(2):163-74.
2010: Richard H Weisler
How do you choose a second-line treatment option for depression?
The Journal of clinical psychiatry 2010;71 Suppl 1():21-6.
2009: Lenard A Adler; Richard H Weisler; David W Goodman; Mohamed Hamdani; Gwendolyn E Niebler
Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2009;70(12):1652-61.
2009: Richard H Weisler; Joel Young; Greg Mattingly; Joseph Gao; Liza Squires; Lenard Adler
Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.
CNS spectrums 2009;14(10):573-85.
2009: Richard H Weisler; Mark Joyce; Lora McGill; Arthur Lazarus; Johan Szamosi; Hans Åke Eriksson
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.
CNS spectrums 2009;14(6):299-313.
2008: Thomas J Spencer; Jeanne M Landgraf; Lenard A Adler; Richard H Weisler; Colleen S Anderson; Sharon H Youcha
Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2008;69(11):1766-75.
2008: Lenard A Adler; David W Goodman; Scott H Kollins; Richard H Weisler; Suma Krishnan; Yuxin Zhang; Joseph Biederman
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
The Journal of clinical psychiatry 2008;69(9):1364-73.
2008: Thomas J Spencer; Lenard A Adler; Richard H Weisler; Sharon H Youcha
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study.
The Journal of clinical psychiatry 2008;69(9):1437-48.
2008: Elisa Cascade; Amir Kalali; Richard H Weisler
Short-acting versus Long-acting Medications for the Treatment of ADHD.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(8):24-7.
2008: Elisa Cascade; Amir Kalali; Richard H Weisler
Varying uses of anticonvulsant medications.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(6):31-3.
2008: Richard H Weisler; Amir Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(5):49-60.
2008: Richard H Weisler; Joseph Calabrese; Michael E Thase; Robert Arvekvist; Göran Stening; Björn Paulsson; Trisha Suppes
Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies.
The Journal of clinical psychiatry 2008;69(5):769-82.
2008: Richard H Weisler; Joseph Calabrese; Charles L Bowden; John A Ascher; Joseph DeVeaugh-Geiss; Gary Evoniuk
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Journal of affective disorders 2008;108(1-2):1-9.
2008: Richard H Weisler; Amir Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(3):35-48.
2008: Elisa Cascade; Amir Kalali; Richard H Weisler; Susan Lenderts
Seasonality and the changing adult/child prescription ratios in ADHD therapy.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(1):23-5.
2008: Rif S el-Mallakh; Terence A Ketter; Richard H Weisler; Robert M A Hirschfeld; Andrew J Cutler; Thomas Gazda; Paul E Keck; Alan C Swann; Amir Kalali
Switching from other agents to extended-release carbamazepine in acute mania.
Psychopharmacology bulletin 2008;41(1):52-8.
2007: Richard H Weisler
Emerging drugs for attention-deficit/hyperactivity disorder.
Expert opinion on emerging drugs 2007;12(3):423-34.
2007: Richard H Weisler
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.
Expert opinion on pharmacotherapy 2007;8(6):745-58.
2006: Michael E Thase; Wayne Macfadden; Richard H Weisler; William Chang; Björn Paulsson; Arifulla Khan; Joseph Calabrese
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Journal of clinical psychopharmacology 2006;26(6):600-9.
2006: Rif S el-Mallakh; Richard H Weisler; Mark H Townsend; Lawrence D Ginsberg
Bipolar II disorder: current and future treatment options.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2006;18(4):259-66.
2006: Richard H Weisler; Andrew J Cutler; James C Ballenger; Robert M Post; Terence A Ketter
The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.
CNS spectrums 2006;11(10):788-99.
2006: Richard H Weisler; James G Barbee; Mark H Townsend
Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita.
JAMA : the journal of the American Medical Association 2006;296(5):585-8.
2006: Richard H Weisler; Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Stephen Faraone; Allan K Chrisman; Stephanie C Read; Simon J Tulloch
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
CNS spectrums 2006;11(8):625-39.
2006: Richard H Weisler
Carbamazepine extended-release capsules in bipolar disorder.
Neuropsychiatric disease and treatment 2006;2(1):3-11.
2006: Robert M A Hirschfeld; Richard H Weisler; Shane R Raines; Wayne Macfadden
Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2006;67(3):355-62.
2006: Thomas J Spencer; Timothy E Wilens; Joseph Biederman; Richard H Weisler; Stephanie C Read; Raymond Pratt
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Clinical therapeutics 2006;28(2):266-79.
2006: Richard H Weisler; Robert M A Hirschfeld; Andrew J Cutler; Thomas Gazda; Terence A Ketter; Paul E Keck; Alan Swann; Amir Kalali
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
CNS drugs 2006;20(3):219-31.
2006: Kathryn M Connor; Jonathan R T Davidson; Richard H Weisler; Wei Zhang; Kurian Abraham
Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.
Psychopharmacology 2006;184(1):21-5.
2005: Richard H Weisler; Joseph Biederman; Thomas J Spencer; Timothy E Wilens
Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
CNS spectrums 2005;10(12 Suppl 20):35-43.
2005: David W Goodman; Lawrence Ginsberg; Richard H Weisler; Andrew J Cutler; Paul Hodgkins
An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.
CNS spectrums 2005;10(12 Suppl 20):26-34.
2005: Joseph Biederman; Thomas J Spencer; Timothy E Wilens; Richard H Weisler; Stephanie C Read; Simon J Tulloch
Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.
CNS spectrums 2005;10(12 Suppl 20):16-25.
2005: Charles L Bowden; Michelle A Collins; Susan L McElroy; Joseph Calabrese; Alan C Swann; Richard H Weisler; Patricia J Wozniak
Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(10):1932-9.
2005: Richard H Weisler
Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.
Expert review of neurotherapeutics 2005;5(5):587-95.
2005: Joseph Calabrese; Paul E Keck; Wayne Macfadden; Margaret Minkwitz; Terence A Ketter; Richard H Weisler; Andrew J Cutler; Robin McCoy; Ellis Wilson; Jamie Mullen
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
The American journal of psychiatry 2005;162(7):1351-60.
2005: Hagop S Akiskal; Matthew A Fuller; Robert M A Hirschfeld; Paul E Keck; Terence A Ketter; Richard H Weisler
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
CNS spectrums 2005;10(6):suppl 1-11; discuss 12-3; quiz 14-5.
2005: Richard H Weisler
Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.
Expert opinion on pharmacotherapy 2005;6(6):1003-18.
2005: Dennis A Revicki; Robert M A Hirschfeld; Eileen P Ahearn; Richard H Weisler; Cynthia Palmer; Paul E Keck
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Journal of affective disorders 2005;86(2-3):183-93.
2005: Jonathan R T Davidson; Kathryn M Connor; Michael A Hertzberg; Richard H Weisler; William H Wilson; Victoria M Payne
Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study.
Journal of clinical psychopharmacology 2005;25(2):166-9.
2005: Richard H Weisler; Paul E Keck; Alan C Swann; Andrew J Cutler; Terence A Ketter; Amir Kalali
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
The Journal of clinical psychiatry 2005;66(3):323-30.
2005: Richard H Weisler
Extended-release carbamazepine capsules: a viewpoint.
CNS drugs 2005;19(8):717-8.
2005: Jonathan R T Davidson; Victoria M Payne; Kathryn M Connor; Edna B Foa; Barbara O Rothbaum; Michael A Hertzberg; Richard H Weisler
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder.
International clinical psychopharmacology 2005;20(1):43-8.
2004: Terence A Ketter; Amir Kalali; Richard H Weisler
A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
The Journal of clinical psychiatry 2004;65(5):668-73.
2004: Richard H Weisler; Amir Kalali; Terence A Ketter
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
The Journal of clinical psychiatry 2004;65(4):478-84.
2003: K Ranga Rama Krishnan; H Cecil Charles; P Murali Doraiswamy; Jacobo E Mintzer; Richard H Weisler; Xin Yu; Carlos A Perdomo; John R Ieni; Sharon Rogers
Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
The American journal of psychiatry 2003;160(11):2003-11.
2003: Atul C Pande; Jerri G Crockatt; Douglas E Feltner; Carol A Janney; Ward T Smith; Richard H Weisler; Peter D Londborg; Robert J Bielski; Dan L Zimbroff; Jonathan R T Davidson; Maria Liu-Dumaw
Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
The American journal of psychiatry 2003;160(3):533-40.
2003: Jonathan R T Davidson; Richard H Weisler; Marian I Butterfield; Charles D Casat; Kathryn M Connor; Stewart Barnett; Susan van Meter
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.
Biological psychiatry 2003;53(2):188-91.
2002: John M Zajecka; Richard H Weisler; Gary Sachs; Alan C Swann; Patricia Wozniak; Kenneth W Sommerville
A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.
The Journal of clinical psychiatry 2002;63(12):1148-55.
2002: Eileen P Ahearn; Marcy C Speer; Y T Chen; David C Steffens; Frederick Cassidy; Susan van Meter; James M Provenzale; Richard H Weisler; K Ranga Rama Krishnan
Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype.
American journal of medical genetics 2002;114(6):652-8.
2002: Richard H Weisler; Susan van Meter
Rapid onset of antidepressant activity with venlafaxine.
The Journal of clinical psychiatry 2002;63(6):534-5; author reply 535-6.
2001: Eileen P Ahearn; Kay Redfield Jamison; David C Steffens; Frederick Cassidy; James M Provenzale; A Lehman; Richard H Weisler; Bernard J Carroll; K Ranga Rama Krishnan
MRI correlates of suicide attempt history in unipolar depression.
Biological psychiatry 2001;50(4):266-70.
2001: Eileen P Ahearn; Frederick Cassidy; L Kelley; Richard H Weisler; Bernard J Carroll
Dimensions of self-rated mood in depressed, manic, and normal subjects.
Comprehensive psychiatry 2001;42(3):196-201.
2000: Kathryn M Connor; Jonathan R T Davidson; L Erik Churchill; A Sherwood; Edna B Foa; Richard H Weisler
Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.
The British journal of psychiatry : the journal of mental science 2000;176():379-86.
1999: P R Knaudt; Kathryn M Connor; Richard H Weisler; L Erik Churchill; Jonathan R T Davidson
Alternative therapy use by psychiatric outpatients.
The Journal of nervous and mental disease 1999;187(11):692-5.
1999: Atul C Pande; Jonathan R T Davidson; James W Jefferson; Carol A Janney; David J Katzelnick; Richard H Weisler; John H Greist; S M Sutherland
Treatment of social phobia with gabapentin: a placebo-controlled study.
Journal of clinical psychopharmacology 1999;19(4):341-8.
1999: Rosario B Hidalgo; Michael A Hertzberg; Thomas A Mellman; F Petty; P Tucker; Richard H Weisler; S Zisook; S Chen; Erik Churchill; J Davidson
Nefazodone in post-traumatic stress disorder: results from six open-label trials.
International clinical psychopharmacology 1999;14(2):61-8.
1999: Kathryn M Connor; Jonathan R T Davidson; S Sutherland; Richard H Weisler
Social phobia: issues in assessment and management.
Epilepsia 1999;40 Suppl 6():S60-5; discussion S73-4.
1999: Kathryn M Connor; Jonathan R T Davidson; Richard H Weisler; Eileen P Ahearn
A pilot study of mirtazapine in post-traumatic stress disorder.
International clinical psychopharmacology 1999;14(1):29-31.
1998: Eileen P Ahearn; David C Steffens; Frederick Cassidy; Susan van Meter; James M Provenzale; Michael F Seldin; Richard H Weisler; K Ranga Rama Krishnan
Familial leukoencephalopathy in bipolar disorder.
The American journal of psychiatry 1998;155(11):1605-7.
1998: Jonathan R T Davidson; Richard H Weisler; ML Malik; Kathryn M Connor
Treatment of posttraumatic stress disorder with nefazodone.
International clinical psychopharmacology 1998;13(3):111-3.
1997: Richard H Weisler; Eileen P Ahearn; Jonathan R T Davidson; C D Wallace
Adjunctive use of olanzapine in mood disorders: five case reports.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1997;9(4):259-62.
1994: Richard H Weisler; JA Johnston; C G Lineberry; B Samara; R J Branconnier; A A Billow
Comparison of bupropion and trazodone for the treatment of major depression.
Journal of clinical psychopharmacology 1994;14(3):170-9.
1990: C G Lineberry; JA Johnston; R N Raymond; B Samara; J P Feighner; N E Harto; R P Granacher; Richard H Weisler; J S Carman; W F Boyer
A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
The Journal of clinical psychiatry 1990;51(5):194-9.